This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
rsi: Archive
Atlanticus Holdings Corporation (ATLC) Loses -20.01% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Atlanticus Holdings Corporation (ATLC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
ATLCPositive Net Change
rsi stock-price-movement
Down -22.17% in 4 Weeks, Here's Why Surgery Partners (SGRY) Looks Ripe for a Turnaround
by Zacks Equity Research
Surgery Partners (SGRY) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
SGRYNegative Net Change
rsi stock-price-movement
After Plunging -29.54% in 4 Weeks, Here's Why the Trend Might Reverse for Oncolytics Biotech Inc. (ONCY)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Oncolytics Biotech Inc. (ONCY) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
ONCYPositive Net Change
rsi stock-price-movement
Down -64.71% in 4 Weeks, Here's Why Mersana Therapeutics, Inc. (MRSN) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Mersana Therapeutics, Inc. (MRSN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
MRSNPositive Net Change
rsi stock-price-movement
Down -23.95% in 4 Weeks, Here's Why Virgin Galactic (SPCE) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Virgin Galactic (SPCE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
SPCEPositive Net Change
rsi stock-price-movement
Down -26.38% in 4 Weeks, Here's Why You Should You Buy the Dip in Emergent Biosolutions (EBS)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Emergent Biosolutions (EBS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
EBSNegative Net Change
rsi stock-price-movement
Down -46.88% in 4 Weeks, Here's Why FibroGen (FGEN) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for FibroGen (FGEN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
FGENPositive Net Change
rsi stock-price-movement
Bentley Systems, Incorporated (BSY) Loses -14.49% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Bentley Systems, Incorporated (BSY) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
BSYPositive Net Change
rsi stock-price-movement
GameStop (GME) Loses -12.53% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
GameStop (GME) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
GMEPositive Net Change
rsi stock-price-movement
After Plunging -15.94% in 4 Weeks, Here's Why the Trend Might Reverse for Allegiant Travel (ALGT)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Allegiant Travel (ALGT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
ALGTNegative Net Change
rsi stock-price-movement
Here's Why P3 Health Partners Inc. (PIII) is Poised for a Turnaround After Losing -28.57% in 4 Weeks
by Zacks Equity Research
P3 Health Partners Inc. (PIII) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
PIIIPositive Net Change
rsi stock-price-movement
Hillenbrand (HI) Loses -9.82% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Hillenbrand (HI) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
HIPositive Net Change
rsi stock-price-movement
Down -16.14% in 4 Weeks, Here's Why You Should You Buy the Dip in Altair Engineering (ALTR)
by Zacks Equity Research
Altair Engineering (ALTR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
rsi stock-price-movement
Down -20.85% in 4 Weeks, Here's Why Beam Therapeutics Inc. (BEAM) Looks Ripe for a Turnaround
by Zacks Equity Research
Beam Therapeutics Inc. (BEAM) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
BEAMNegative Net Change
rsi stock-price-movement
Down -14.3% in 4 Weeks, Here's Why Allegiant Travel (ALGT) Looks Ripe for a Turnaround
by Zacks Equity Research
Allegiant Travel (ALGT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
ALGTNegative Net Change
rsi stock-price-movement
Down -18.35% in 4 Weeks, Here's Why You Should You Buy the Dip in Altair Engineering (ALTR)
by Zacks Equity Research
Altair Engineering (ALTR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
rsi stock-price-movement
Down -65.65% in 4 Weeks, Here's Why You Should You Buy the Dip in Theseus Pharmaceuticals, Inc. (THRX)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Theseus Pharmaceuticals, Inc. (THRX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
THRXPositive Net Change
rsi stock-price-movement
Down -15.01% in 4 Weeks, Here's Why Bel Fuse (BELFB) Looks Ripe for a Turnaround
by Zacks Equity Research
Bel Fuse (BELFB) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
BELFBNegative Net Change
rsi stock-price-movement
After Plunging -12.51% in 4 Weeks, Here's Why the Trend Might Reverse for DoubleDown Interactive Co., Ltd. Sponsored ADR (DDI)
by Zacks Equity Research
DoubleDown Interactive Co., Ltd. Sponsored ADR (DDI) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
DDINegative Net Change
rsi stock-price-movement
Down -11.65% in 4 Weeks, Here's Why You Should You Buy the Dip in Belden (BDC)
by Zacks Equity Research
Belden (BDC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
BDCNegative Net Change
rsi stock-price-movement
Angi (ANGI) Loses -26% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Angi (ANGI) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
ANGIPositive Net Change
rsi stock-price-movement
Down -7.52% in 4 Weeks, Here's Why You Should You Buy the Dip in Kenvue (KVUE)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Kenvue (KVUE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
KVUENegative Net Change
rsi stock-price-movement
Down -19.41% in 4 Weeks, Here's Why Model N (MODN) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Model N (MODN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
MODNPositive Net Change
rsi stock-price-movement
Here's Why Viridian Therapeutics, Inc. (VRDN) is Poised for a Turnaround After Losing -20.23% in 4 Weeks
by Zacks Equity Research
Viridian Therapeutics, Inc. (VRDN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
VRDNNegative Net Change
rsi stock-price-movement
ALX Oncology Holdings Inc. (ALXO) Loses -18.84% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for ALX Oncology Holdings Inc. (ALXO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
ALXONegative Net Change
rsi stock-price-movement